GLP1R Variants and Polygenic Risk Underlie Heterogeneous Response to GLP-1 Receptor Agonists in Type 2 Diabetes
Munichandra Babu Tirumalasetty, Vivian Hsing-Chun Wang, Mohammad Sarif Mohiuddin, Mayank Choubey, Rashu Barua, Donglan “Stacy” Zhang, Qing Miao
This study identifies genetic and clinical factors influencing glycemic response to GLP-1 receptor agonists in type 2 diabetes, showing that polygenic risk and GLP1R variants are associated with response variability.
medRxiv · Aug 2, 2026 · PreprintGenetic & Genomic Medicine